ATE269872T1 - Methode zur herstellung von im wesentlichen monomeren normalen menschlichen serum-albumin - Google Patents

Methode zur herstellung von im wesentlichen monomeren normalen menschlichen serum-albumin

Info

Publication number
ATE269872T1
ATE269872T1 AT91105453T AT91105453T ATE269872T1 AT E269872 T1 ATE269872 T1 AT E269872T1 AT 91105453 T AT91105453 T AT 91105453T AT 91105453 T AT91105453 T AT 91105453T AT E269872 T1 ATE269872 T1 AT E269872T1
Authority
AT
Austria
Prior art keywords
preparation
composition
human serum
essentially
aluminum
Prior art date
Application number
AT91105453T
Other languages
English (en)
Inventor
Robert A Tenold
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE269872T1 publication Critical patent/ATE269872T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91105453T 1990-04-19 1991-04-06 Methode zur herstellung von im wesentlichen monomeren normalen menschlichen serum-albumin ATE269872T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51136290A 1990-04-19 1990-04-19

Publications (1)

Publication Number Publication Date
ATE269872T1 true ATE269872T1 (de) 2004-07-15

Family

ID=24034566

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91105453T ATE269872T1 (de) 1990-04-19 1991-04-06 Methode zur herstellung von im wesentlichen monomeren normalen menschlichen serum-albumin

Country Status (6)

Country Link
EP (1) EP0452753B1 (de)
JP (2) JP3009242B2 (de)
AT (1) ATE269872T1 (de)
CA (1) CA2040036A1 (de)
DE (1) DE69133399T2 (de)
ES (1) ES2224094T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230273T2 (de) * 1991-07-12 2000-05-31 Dsm N.V., Heerlen Verfahren zur Reinigung von Serumalbumin
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
EP1500661A1 (de) 1998-06-01 2005-01-26 Genetech, Inc. Trennung von Protein-Monomeren von Aggregaten mittels Ionaustausch-Chromatographie
DE19830914C1 (de) * 1998-07-10 1999-06-24 Centeon Pharma Gmbh Verfahren zur Herstellung einer Proteinlösung
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
AU3624400A (en) * 1999-03-19 2000-10-09 Bayer Corporation Chromatographic albumin process
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
WO2016207353A1 (en) * 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1196636A (en) * 1967-03-01 1970-07-01 Ustav Ser A Ockovacich Latek O Process for the Preparation of Pure Albumins from Normal and Haemolysed Sera and Plasma
US3926939A (en) * 1973-08-24 1975-12-16 Mikhail Ivanovich Ivanov Method of extracting pure serum albumin from biological fluids using a salt of a carboxylic aliphatic acid
US4156681A (en) * 1974-03-28 1979-05-29 Plasmesco Ag Process for isolating albumin from blood
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
JPS62294621A (ja) * 1986-06-13 1987-12-22 Green Cross Corp:The アルブミンの回収方法

Also Published As

Publication number Publication date
ES2224094T3 (es) 2005-03-01
JPH0733800A (ja) 1995-02-03
JP2000095798A (ja) 2000-04-04
DE69133399D1 (de) 2004-07-29
JP3009242B2 (ja) 2000-02-14
EP0452753A1 (de) 1991-10-23
CA2040036A1 (en) 1991-10-20
DE69133399T2 (de) 2005-06-30
EP0452753B1 (de) 2004-06-23

Similar Documents

Publication Publication Date Title
ATE269872T1 (de) Methode zur herstellung von im wesentlichen monomeren normalen menschlichen serum-albumin
Latallo et al. Influence of pH, ionic strength, neutral ions, and thrombin on fibrin polymerization
Scawen et al. The action of proteolytic enzymes on the glycoprotein from pig gastric mucus
Kahane Cross‐linking of red blood cell membrane proteins induced by oxidative stress in β thalassemia
BR9407003A (pt) Preparaçao e estabilizaçao de células
RU94046291A (ru) Способ профилактики и лечения периферической невропатии, композиция, содержащая инсулин-подобный фактор роста i
HUP9900920A2 (hu) Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
NZ210275A (en) Modified hirudin and its antithrombin properties
EP1074615A1 (de) Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
FR2506944A1 (fr) Procede de stabilisation de plaquettes, composition fixative-stabilisante a ajouter, et procede pour fixer et stabiliser les plaquettes
HUT58813A (en) Process for producing tissue-plasminogen activator derivative
ATE242015T1 (de) Zusammensetzung und verfahren zur zersetzung von wasserstoffperoxid
Mann et al. The molecular weights of bovine thrombin and its primary autolysis products
Louis et al. The proteins of rabbit skeletal muscle sarcoplasmic reticulum
Kang et al. Interaction of an Active Glycopeptide from Chick Skin Collagen (αl-CB5) with Human Platelets
Lanchantin et al. Amino acid composition of human plasma prothrombin
ATE172206T1 (de) Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP0139975B1 (de) Verfahren zur Pasteurisierung von Humanplasma
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
Inman et al. Reversible dissociation of fragment Fc of rabbit γG-immunoglobulin
Lee et al. Inhibition of the self-assembly of tubulin by diethylpyrocarbonate and photooxidation
HUT47374A (en) Fungicide compositions containing /2-cyano-2-oximino-acetyl/-aminoacid derivatives as active components and process for producing the active components
EP0536564B1 (de) Verfahren zur Reinigung von Streptolysin 0, intaktes Streptolysin 0 erhältlich nach diesem Verfahren und seine Verwendung
FR2444714A1 (fr) Procede servant a la degradation enzymatique partielle ou totale d'une substance faiblement moleculaire

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties